Biosimilars North America 2017

September 19, 2017 4:27 PM


SMi Group is organizing the Biosimilars North America Congress 2017 in New Jersey, USA.

As the biosimilar industry continues to flourish, paving opportunities for commercial progression for pharma and biotech companies, now is a favorable time to get involved. Biosimilars North America 2017 will provide an intelligent meeting to explore novel and innovative strategies to advance biosimilar development, and ensure optimal market access and commercialization importunities whilst complying with evolving regulatory requirements. This year, the conference will take on significant topics and more updates this year focusing on regulatory aspects, biosimilar development, CMC, biosimilars of orphan drugs and lessons learnt from success stories. Some key highlights include:

  • A presentation from Sandoz on the FDA issuing the long-awaited biosimilar interchangeability guidance
  • A session on complex biosimilars and new technologies from MedImmune
  • Momenta Pharmaceuticals will provide strategies to combat legal, policy and commercial obstacles to development and launch
  • Insights on latest development and market access strategies from FUJIFILMDiosynth Biotechnologies
  • A talk on drug product and formulation development considerations with Oncobiologics
  • A session discussing the implications of the recent ruling on the Amgen v Sandoz case
  • Presentations on formulation development considerations for biosimilar orphans

…and many more! This is just a snapshot of what you can gain from attending Biosimilars North America 2017.

The full roster of speakers can be found on

Would you like to post an event on Biosimilar News?

Leave a Reply

Twitter ID
(ID only. No links or "@" symbols)

Latest News on Biosimilar News

Share an Article?

Writing an article is not only a great way to share your knowledge, but it is also a great way to give back to the community.

We value all our contributors and if you have a website, we will surely give a link back to your site and products.
Wanna contribute?


Biosimilar News was started for the people who are interested in this rapidly growing business area. So if you have suggestions or feedback on how we can improve, please let us know. If you want to see a specific topic covered, answer to a specific question, or anything else of this sort, just write us. We do our best to keep up!
Make a suggestion now!